Inspire Medical Clocks 70% Increase In Q4 Sales, Issues FY22 Guidance Ahead Of Consensus
Inspire Medical Systems Inc (NYSE: INSP) generated revenue of
SVB Leerink Maintains Outperform on Inspire Medical Systems, Raises Price Target to $273
SVB Leerink analyst Danielle Antalffy maintains Inspire Medical Systems (NYSE:INSP) with a Outperform and raises the price target from $270 to $273.
Inspire Medical Systems: Q4 Earnings Insights
Inspire Medical Systems (NYSE:INSP) reported its Q4 earnings results on Tuesday, February 8, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
The Daily Biotech Pulse: Pfizer, Amgen Shares Slip On Earnings, Editas Terminates Chief Medical Officer, Biogen Licenses Preclinical Rheumatoid Arthritis Biosimilar
Here's a roundup of top developments in the biotech space over the last 24 hours:
Earnings Scheduled For February 8, 2022
Companies Reporting Before The Bell
• Pfizer (NYSE:PFE) is likely to report quarterly earnings at $0.87 per share on revenue of $24.20 billion.
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big pharma earnings. The sector came back up in the final session for a firm finish.
Inspire Medical Expects Strong Q4 FY21 Revenue Growth
Inspire Medical Systems Inc (NYSE:INSP) expects Q4 FY21 revenue of $78.0 million – $78.4 million, up approximately 70% Y/Y and…
5 Stocks To Watch For January 5, 2022
Some of the stocks that may grab investor focus today are:
Wall Street expects RPM International Inc. (NYSE: RPM) to report quarterly earnings at $0.83 per share on revenue of $1.55 billion before the opening bell. RPM shares gained 0.1% to $97.21 in after-hours trading.
Inspire Medical Systems Offers Update On 2022 Amublatory Surgical Center Reimbursement Levels
Inspire Medical Systems, Inc. (NYSE:INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with